Pharmaceutical biotechnology
"The book gives you a working knowledge of the preparation, stability, and formulation of protein and peptide drugs. The author examines the successful evolution of humanized monoclonal antibodies to treat rheumatoid arthritis and other diseases. He discusses the currently disappointing results...
Saved in:
Other Authors: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
Boca Raton, FL :
Taylor & Francis,
2006.
|
Edition: | 2nd ed. |
Subjects: | |
ISBN: | 0203508831 9780203508831 9781420025866 1420025864 9781628707724 1628707720 0849318734 9780849318733 |
Physical Description: | 1 online resource (411 pages) : illustrations |
LEADER | 04097cam a22004694a 4500 | ||
---|---|---|---|
001 | kn-ocm62704390 | ||
003 | OCoLC | ||
005 | 20240717213016.0 | ||
006 | m o d | ||
007 | cr cn||||||||| | ||
008 | 051219s2006 flua ob 001 0 eng d | ||
040 | |a N$T |b eng |e pn |c N$T |d OCLCQ |d YDXCP |d OCLCG |d OCLCQ |d IDEBK |d OCLCQ |d UV0 |d CAI |d E7B |d TULIB |d OCLCQ |d OCLCF |d KNOVL |d SLY |d ZCU |d CRCPR |d OCLCQ |d KNOVL |d OCLCQ |d TOA |d COCUF |d OCLCQ |d YDX |d WY@ |d OCLCO |d OCLCA |d LUE |d OCLCO |d CASUM |d WCO |d OCLCO |d OCLCQ |d XOS |d OCLCQ |d OCLCO |d WYU |d OCLCA |d TYFRS |d LEAUB |d SFB |d OCLCO |d OCLCQ |d OCLCO |d OCLCL | ||
020 | |a 0203508831 |q (electronic bk.) | ||
020 | |a 9780203508831 |q (electronic bk.) | ||
020 | |a 9781420025866 |q (electronic bk.) | ||
020 | |a 1420025864 |q (electronic bk.) | ||
020 | |a 9781628707724 |q (electronic bk.) | ||
020 | |a 1628707720 |q (electronic bk.) | ||
020 | |a 0849318734 | ||
020 | |a 9780849318733 | ||
020 | |z 9780849318733 | ||
020 | |z 0849318734 | ||
024 | 3 | |a 9780849318733 | |
035 | |a (OCoLC)62704390 |z (OCoLC)228141364 |z (OCoLC)228141365 |z (OCoLC)276791405 |z (OCoLC)647618241 |z (OCoLC)779922509 |z (OCoLC)880329743 |z (OCoLC)991989473 |z (OCoLC)1007409578 |z (OCoLC)1024285915 |z (OCoLC)1066614053 |z (OCoLC)1125411873 |z (OCoLC)1136170709 | ||
245 | 0 | 0 | |a Pharmaceutical biotechnology / |c edited by Michael J. Groves. |
250 | |a 2nd ed. | ||
260 | |a Boca Raton, FL : |b Taylor & Francis, |c 2006. | ||
300 | |a 1 online resource (411 pages) : |b illustrations | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
504 | |a Includes bibliographical references and index. | ||
505 | 0 | 0 | |t Proteins / |r Charles P. Woodbury, Jr. -- |t Recombinant DNA basics / |r Charles P. Woodbury, Jr. -- |t Monoclonal antibodies / |r David J. Groves -- |t Proteomics a new emerging area of biotechnology / |r N.O. Sahin -- |t Commonly used analytical techniques for biotechnology products / |r Wei Tang, Kadriye Ciftci -- |t Formulation of proteins and peptides / |r Michael J. Groves -- |t Proteins as drug delivery systems / |r Michael J. Groves -- |t Proteins and phospholipids / |r Michael J. Groves -- |t Pulmonary drug delivery systems for biomacromolecules / |r Camellia Zamiri, Richard A. Gemeinhart -- |t Polymeric systems for oral protein and peptide delivery / |r Richard A. Gemeinhart -- |t Vaccines : ancient medicines to modern therapeutics / |r H.O. Alpar, Michael J. Groves -- |t Gene therapy : an overview of the current viral and nonviral vectors / |r Kadriye Ciftci, Anshul Gupte -- |t Regulatory and compendial issues / |r Michael J. Groves -- |t Some challenges relating to the future of biopharmaceutical technology / |r Michael J. Groves. |
506 | |a Plný text je dostupný pouze z IP adres počítačů Univerzity Tomáše Bati ve Zlíně nebo vzdáleným přístupem pro zaměstnance a studenty | ||
520 | 1 | |a "The book gives you a working knowledge of the preparation, stability, and formulation of protein and peptide drugs. The author examines the successful evolution of humanized monoclonal antibodies to treat rheumatoid arthritis and other diseases. He discusses the currently disappointing results of genetic engineering and genomics that have isolated disease-responsible genes without significant clinical effect. The book covers the market and scientific reasons behind the failure of many biotechnology products to live up to their hype. It concludes with a discussion of regulatory and compendial issues and a look at future challenges facing biotechnology."--Jacket. | |
590 | |a Knovel |b Knovel (All titles) | ||
650 | 0 | |a Pharmaceutical biotechnology. | |
655 | 7 | |a elektronické knihy |7 fd186907 |2 czenas | |
655 | 9 | |a electronic books |2 eczenas | |
700 | 1 | |a Groves, M. J. |q (Michael John) |1 https://id.oclc.org/worldcat/entity/E39PCjFcck46VPBDM9F84gFdwC | |
776 | 0 | 8 | |i Print version: |t Pharmaceutical biotechnology. |b 2nd ed. |d Boca Raton, FL : Taylor & Francis, 2006 |z 0849318734 |w (DLC) 2005043707 |w (OCoLC)58545984 |
856 | 4 | 0 | |u https://proxy.k.utb.cz/login?url=https://app.knovel.com/hotlink/toc/id:kpPBE00006/pharmaceutical-biotechnology-2nd?kpromoter=marc |y Full text |